XGN
Exagen Inc

564
Loading...
Loading...
News
all
press releases
Exagen Inc. (XGN) Reports Q2 Loss, Beats Revenue Estimates
Exagen (XGN) delivered earnings and revenue surprises of 0.00% and +7.51%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
More News
News Placeholder
Exagen (XGN) Soars 5.5%: Is Further Upside Left in the Stock?
Exagen (XGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks·3mo ago
News Placeholder
Q1 2024 EPS Estimates for Exagen Inc. (NASDAQ:XGN) Decreased by Analyst
Exagen Inc. (NASDAQ:XGN Free Report) William Blair reduced their Q1 2024 earnings estimates for shares of Exagen in a note issued to investors on Monday, March 18th. William Blair...
Ticker Report·2y ago
News Placeholder
Exagen (NASDAQ:XGN) Announces Quarterly Earnings Results, Misses Expectations By $0.02 EPS
Exagen (NASDAQ:XGN Get Free Report) announced its quarterly earnings data on Monday. The company reported ($0.43) earnings per share (EPS) for the quarter, missing the consensus estimate of...
Ticker Report·2y ago
News Placeholder
Q4 2023 Exagen Inc Earnings Call Transcript
Related Stocks: NAS:XGN...
GuruFocus·2y ago
News Placeholder
Exagen continues to execute on re-acceleration strategy, says Canaccord
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago
News Placeholder
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
CARLSBAD, Calif., March 18, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the fourth quarter and full...
Globe Newswire·2y ago
News Placeholder
Exagen Inc. (NASDAQ:XGN) CFO Sells $24,417.44 in Stock
Exagen Inc. (NASDAQ:XGN Get Free Report) CFO Kamal Adawi sold 12,784 shares of the businesss stock in a transaction dated Monday, March 4th. The stock was sold at an average price of...
Ticker Report·2y ago
News Placeholder
Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
CARLSBAD, Calif., March 08, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the KeyBanc Capital Markets...
Globe Newswire·2y ago
News Placeholder
Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024
CARLSBAD, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release financial results for the quarter and year ended December 31...
Globe Newswire·2y ago

Latest XGN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.